Miriam Erlacher
- Immunology top 5%
- Immune Cell Function and Interaction 10
- Phagocytosis and Immune Regulation 10
- Hematology top 5%
- Acute Myeloid Leukemia Research 17
- Hematopoietic Stem Cell Transplantation 10
- Molecular Biology top 5%
- Cell death mechanisms and regulation 24
- RNA Interference and Gene Delivery 7
- Cell Biology top 5%
- Oncology top 5%
-
- Chronic Lymphocytic Leukemia Research 7
- Blood disorders and treatments 7
- Co-authors
- Verena LabiAndreas VillungerAndreas StrasserEwa M. MichalakGeorg HäckerClaudia ManzlStephan KießlingHan You
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Clinical Investigation (1 paper)The Journal of Experimental Medicine (6 papers)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Miriam Erlacher
69 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 97
- Immunology 641
- Hematology 330
- Molecular Biology 1.6k
- Cell Biology 348
- Oncology 561
Countries citing papers authored by Miriam Erlacher
This map shows the geographic impact of Miriam Erlacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miriam Erlacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miriam Erlacher more than expected).
Fields of papers citing papers by Miriam Erlacher
This network shows the impact of papers produced by Miriam Erlacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miriam Erlacher. The network helps show where Miriam Erlacher may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Miriam Erlacher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 7 | |
| 5 | 2023 | 20 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 23 | |
| 10 | 2022 | 25 | |
| 11 | 2022 | 1 | |
| 12 | 2022 | 0 | |
| 13 | 2021 | 13 | |
| 14 | 2021 | 10 | |
| 15 | 2019 | 23 | |
| 16 | 2015 | 209 | |
| 17 | 2009 | 1 | |
| 18 | 2008 | 98 | |
| 19 | Involvement of Bcl-2 family proteins in Gleevec's mechanism of action | 2006 | 1 |
| 20 | 2005 | 22 |
About Miriam Erlacher
Miriam Erlacher is a scholar working on Hematology, Immunology and Genetics, having authored 78 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (24 papers), Acute Myeloid Leukemia Research (17 papers), Hematopoietic Stem Cell Transplantation (10 papers), Immune Cell Function and Interaction (10 papers), Phagocytosis and Immune Regulation (10 papers), Chronic Lymphocytic Leukemia Research (7 papers), RNA Interference and Gene Delivery (7 papers) and Blood disorders and treatments (7 papers). The work is most often cited by research in Immunology (641 citations), Hematology (330 citations) and Molecular Biology (1.6k citations). Miriam Erlacher has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Verena Labi, Andreas Villunger, Andreas Strasser, Ewa M. Michalak, Georg Häcker, Claudia Manzl, Stephan Kießling, Han You, Kazuo Yamamoto and Katsuya Tsuchihara. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.